alpha-(n6-adenyl)styrene oxide has been researched along with 6-ethyl-N-[2-(4-methoxyphenyl)ethyl]-5-methyl-[1,2,4]triazolo[1,5-a]pyrimidin-7-amine in 1 studies
| Studies (alpha-(n6-adenyl)styrene oxide) | Trials (alpha-(n6-adenyl)styrene oxide) | Recent Studies (post-2010) (alpha-(n6-adenyl)styrene oxide) | Studies (6-ethyl-N-[2-(4-methoxyphenyl)ethyl]-5-methyl-[1,2,4]triazolo[1,5-a]pyrimidin-7-amine) | Trials (6-ethyl-N-[2-(4-methoxyphenyl)ethyl]-5-methyl-[1,2,4]triazolo[1,5-a]pyrimidin-7-amine) | Recent Studies (post-2010) (6-ethyl-N-[2-(4-methoxyphenyl)ethyl]-5-methyl-[1,2,4]triazolo[1,5-a]pyrimidin-7-amine) |
|---|---|---|---|---|---|
| 8 | 0 | 2 | 6 | 0 | 1 |
| Protein | Taxonomy | alpha-(n6-adenyl)styrene oxide (IC50) | 6-ethyl-N-[2-(4-methoxyphenyl)ethyl]-5-methyl-[1,2,4]triazolo[1,5-a]pyrimidin-7-amine (IC50) |
|---|---|---|---|
| galanin receptor type 3 | Homo sapiens (human) | 3.202 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Butkiewicz, M; Lowe, EW; Meiler, J; Mendenhall, JL; Mueller, R; Teixeira, PL; Weaver, CD | 1 |
1 other study(ies) available for alpha-(n6-adenyl)styrene oxide and 6-ethyl-N-[2-(4-methoxyphenyl)ethyl]-5-methyl-[1,2,4]triazolo[1,5-a]pyrimidin-7-amine
| Article | Year |
|---|---|
Benchmarking ligand-based virtual High-Throughput Screening with the PubChem database.
Topics: Algorithms; Animals; Area Under Curve; Computer Simulation; Databases, Chemical; Decision Trees; Drug Discovery; High-Throughput Screening Assays; Humans; Inhibitory Concentration 50; Ligands; Models, Chemical; Neural Networks, Computer; Quality Improvement; Quantitative Structure-Activity Relationship; ROC Curve; Support Vector Machine | 2013 |